Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingegerd Hellstrom

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Letters|April 13, 2010
Detection of the HE4 protein in urine as a biomarker for ovarian neoplasmsIngegerd Hellstrom, Patrick J Heagerty, Elizabeth M Swisher, et al.
Journal of Ovarian Research|August 2, 2011
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumorsYi Yu, Seby L Edassery, Animesh Barua, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammationMin Dai, Huafeng Wei, Yuen Yee Yip, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2004
Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137Shilin Yang, Yi Yang, John Raycraft, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 18, 2011
Autoantibodies to mesothelin in infertilityJudith L Luborsky, Yi Yu, Seby L Edassery, et al.
Reproduction (Cambridge, England)|December 15, 2016
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancerYi Yu-Rice, Seby L Edassery, Nicole Urban, et al.
Journal of the American Chemical Society|May 4, 2010
Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapyChenghong Lei, Pu Liu, Baowei Chen, et al.
Lancet (London, England)|November 25, 2003
Mesothelin-family proteins and diagnosis of mesotheliomaBruce W S Robinson, Jenette Creaney, Richard Lake, et al.
Respiratory Research|April 8, 2006
WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lungLynne Bingle, Simon S Cross, Alec S High, et al.
Plos One|December 25, 2013
Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatinHuafeng Wei, Likun Zhao, Wei Li, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Letters|April 13, 2010
Detection of the HE4 protein in urine as a biomarker for ovarian neoplasmsIngegerd Hellstrom, Patrick J Heagerty, Elizabeth M Swisher, et al.
Journal of Ovarian Research|August 2, 2011
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumorsYi Yu, Seby L Edassery, Animesh Barua, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammationMin Dai, Huafeng Wei, Yuen Yee Yip, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2004
Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137Shilin Yang, Yi Yang, John Raycraft, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 18, 2011
Autoantibodies to mesothelin in infertilityJudith L Luborsky, Yi Yu, Seby L Edassery, et al.
Reproduction (Cambridge, England)|December 15, 2016
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancerYi Yu-Rice, Seby L Edassery, Nicole Urban, et al.
Journal of the American Chemical Society|May 4, 2010
Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapyChenghong Lei, Pu Liu, Baowei Chen, et al.
Lancet (London, England)|November 25, 2003
Mesothelin-family proteins and diagnosis of mesotheliomaBruce W S Robinson, Jenette Creaney, Richard Lake, et al.
Respiratory Research|April 8, 2006
WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lungLynne Bingle, Simon S Cross, Alec S High, et al.
Plos One|December 25, 2013
Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatinHuafeng Wei, Likun Zhao, Wei Li, et al.
Pageof 4